GALNTL4-PRDM2 Fusion FISH Probe
The GALNTL4-PRDM2 Fusion FISH Probe is used to confirm a fusion of the GALNTL4 and PRDM2 genes. The fusion of the GALNTL4 and PRDM2 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GALNTL4-PRDM2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GALNTL4-PRDM2-20-AQAQ | 20 (40 μL) | 200 μL |
|
PRDM2 Gene Summary
This tumor suppressor gene is a member of a nuclear histone/protein methyltransferase superfamily. It encodes a zinc finger protein that can bind to retinoblastoma protein, estrogen receptor, and the TPA-responsive element (MTE) of the heme-oxygenase-1 gene. Although the functions of this protein have not been fully characterized, it may (1) play a role in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma, (2) act as a transcriptional activator of the heme-oxygenase-1 gene, and (3) be a specific effector of estrogen action. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Gene Name: PR/SET Domain 2
Chromosome: CHR1: 14026734 -14151574
Locus: 1p36.21
Gene Diseases
The GALNTL4 PRDM2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|